PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
02-Aug-2023 WITH GREAT SADNESS TRYP ANNOUNCES THE PASSING OF DAVID TOUSLEY, DIRECTOR Tryp Therapeutics Inc.
02-Aug-2023 Epigenomics AG: Capital reduction planned at a ratio of 5 : 1 Epigenomics AG
01-Aug-2023 Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology Zenas BioPharma
01-Aug-2023 ATS PACKAGING TAKES CENTRE STAGE AT PPMA SHOW 2023 ATS PACKAGING
01-Aug-2023 CureVac Announces Dosing of First Participant in Phase 2 Study of Modified COVID-19 mRNA Vaccine Candidates Developed in Collaboration with GSK CureVac
01-Aug-2023 Approval to roll-out chronic pain clinical trial Celadon Pharmaceuticals Plc
01-Aug-2023 Publication of new data demonstrates significantly superior efficacy of XF-73 compared to a leading topical antibiotic against MRSA in skin infection models Destiny Pharma plc
01-Aug-2023 National approval for MOB-015 in Ireland Moberg Pharma AB
01-Aug-2023 Coriolis Pharma and RheaVita Join Forces in Collaboration for Continuous and Controlled Freeze-Drying Technology Coriolis Pharma
01-Aug-2023 Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom Mainz BioMed N.V.
31-Jul-2023 APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued in 2024 APONTIS PHARMA AG
31-Jul-2023 Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants Bio-Gate AG
31-Jul-2023 MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year MeVis Medical Solutions AG
31-Jul-2023 MediClin AG: Higher demand for medical, therapeutic and nursing services led to an increase in sales and earnings in the Group MediClin AG
31-Jul-2023 Coriolis Pharma and RheaVita Join Forces in Collaboration for Continuous and Controlled Freeze-Drying Technology B3C newswire
30-Jul-2023 IGEA Pharma N.V.: IGEA discloses its Annual Report 2022 IGEA Pharma N.V.
28-Jul-2023 OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center OKYO Pharma
28-Jul-2023 GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION’S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030 GILEAD
28-Jul-2023 Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders Vitruvia Medical AG
28-Jul-2023 Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year Evolva Holding SA